Meet Proto: Where Biology Meets Code
What if designing a living cell could one day be as intuitive as writing a line of code?
Researchers at Stanford University and the Arc Institute have introduced Proto, a high-level programming language designed not for machines, but for living systems. Where traditional biological design tools are highly specialised and difficult to combine, Proto works by composing a small set of abstract building blocks into structured programmes that can span DNA, RNA, proteins, ligands, and the interactions between them. The ambition is to give scientists - and eventually AI agents - a single, flexible language for designing biology the way developers design applications. In early tests, the team used Proto to design alternatively spliced introns validated in human cell lines, and to produce promoter-repressor pairs with leading success rates for synthetic protein-DNA design.
What makes Proto particularly exciting is its native support for multiple objectives at once and its ability to incorporate predictive models directly into generative workflows. Rather than running separate, siloed tools for each design task, researchers can describe complex biological pathways and regulatory logic in plain language instructions - with AI agents translating those instructions into Proto programmes. For anyone working in medicine, drug discovery, or synthetic biology, the implications are significant: the same generative AI approaches transforming software development are now being applied to the building blocks of life itself. The Arc Institute has released Proto as an open platform, complete with software infrastructure and user interfaces, meaning these capabilities are available to the wider research community right now.
Of course, it is important to acknowledge that Proto is currently a preprint, and that translating computational biological design into reliable real-world outcomes involves layers of experimental complexity that take time to work through. As with any early-stage research, the methodology will be tested and refined as the community engages with it. What is clear, however, is that the direction of travel is compelling - and the potential for Proto to accelerate how we design therapeutics, engineer new biological functions, and ultimately understand living systems is a prospect well worth watching.
